News & Articles

Register now to join our 3-part webinar series from October

Leveraging duplex NGS with automated library prep, researchers move closer to developing liquid biopsy tests for rare genetic disorders

Find out how Agilent Technologies' Advanced Dilution System 2 (ADS 2) enhances lab efficiency and accuracy, while significantly reducing environmental impacts by minimizing plastic waste and argon usage

Latest mass spectrometry innovations showcased at the this year's annual conference

Are your flow cytometry panels becoming too complex for traditional flow cytometry?

Automated parallel capillary electrophoresis system simplifies protein analysis

Labs seek guidance in reducing their environmental footprint by increasing efficiency but overall convey optimism on sustainability efforts

Streamlined analysis of 40 PFAS compounds in wastewater and soil

The new systems are designed to tackle challenging targeted analysis applications requiring the highest analytical sensitivity

Experience the thrill of speed-dating, digital lab-style

From cancer research to diagnostic solutions

Agilent Technologies showcased its cancer research innovations in cell analysis and genomics at the American Association for Cancer Research Annual Meeting

Agilent will integrate the technology into its lab informatics platforms enabling customers to automate GC/MS data analysis

This collaboration aims to drive innovation in food, nutrition, ingredients, industrial biotechnology, and related applications

The automation platforms from Agilent Technologies deliver powerful solutions to meet customers needs

Optimized for pharma/biopharma to deliver a deeper understanding of cellular function

The collaboration aims to develop and integrate current and new analytical technologies into patient-scale cell therapy manufacturing workflows

New solutions are designed to accelerate the development of new protein-based therapeutics

Agilent has undertaken the highest sponsorship level of My Green Lab and is the first institution to sponsor the My Green Lab certification program

PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify esophageal cancer patients for treatment with KEYTRUDA (pembrolizumab)

Both multi-mode readers feature a modular architecture so that researchers may purchase based on their immediate needs and upgrade the unit